Yaoyanshe, a Chinese clinical research organization (CRO) service provider, has raised RMB300 million (US$42.61 million) in a series C round of financing led by Chinese venture capital firm Eastern Bell Capital and Sequoia Capital China.
Sequoia, Eastern Bell Co-Lead $42M Series C Round In Chinese CRO Service Provider comes originally from China Money Network. All Rights Reserved.